Company News: Page (1) of 1 - 11/26/13 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Achillion to Present at the Three Upcoming Healthcare Conferences

(November 26, 2013)

NEW HAVEN, Conn., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at three upcoming investor conferences:




  • Deutsche Bank 2013 BioFEST on Tuesday, December 3, 2013 at 10:10 a.m. ET at the Four Seasons Hotel Boston in Boston, MA;

     


  • The 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 12:30 p.m. ET at The New York Palace Hotel in New York, NY; and

     


  • Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11, 2013 at 1:35 p.m. ET at the Crowne Plaza Times Square in New York, NY.



The live audio and subsequent archived webcasts of the Company's presentations will be accessible from the Company's investor relations website, http://ir.achillion.com. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.



About Achillion Pharmaceuticals


Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's discovery, clinical development, and commercial teams have advanced multiple novel product candidates with proven mechanisms of action into studies and toward the market. Achillion is focused on solutions for the most challenging problems in infectious disease including HCV and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.



CONTACT: Company Contact:
Glenn Schulman
Achillion Pharmaceuticals, Inc.
Tel. (203) 752-5510
gschulman@achillion.com

Investors:
Mary Kay Fenton
Achillion Pharmaceuticals, Inc.
Tel. (203) 624-7000
mfenton@achillion.com



Achillion Pharmaceuticals logo


Page: 1


Related Keywords: PHARMACEUTICALS, WEBCASTPro AV, Audio Professionals, Presentors, Recording, Live, Business Issues, Internet Media, Presentation, Corporate/Company, Events, webcast, Inc., Disease, healthcare, Surgery, Science, Lifestyle, Medical, Biology,

HOT THREADS on DMN Forums
Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!
Windows OS
fdf • Tom.R  

@ Copyright, 2014 Digital Media Online, All Rights Reserved